BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 31608651)

  • 1. The Dose Response: Perceptions of People Living with HIV in the United States on Alternatives to Oral Daily Antiretroviral Therapy.
    Dubé K; Eskaf S; Evans D; Sauceda J; Saberi P; Brown B; Averitt D; Martel K; Meija M; Campbell D; Barr L; Kanazawa J; Perry K; Patel H; Luter S; Poteat T; Auerbach JD; Wohl DA
    AIDS Res Hum Retroviruses; 2020 Apr; 36(4):324-348. PubMed ID: 31608651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perceptions of HIV Virologic Control Strategies Among Younger and Older Age Groups of People Living with HIV in the United States: A Cross-Sectional Survey.
    Saberi P; Eskaf S; Sauceda J; Evans D; Dubé K
    AIDS Res Hum Retroviruses; 2020 Jul; 36(7):606-615. PubMed ID: 32368934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reasons People Living with HIV Might Prefer Oral Daily Antiretroviral Therapy, Long-Acting Formulations, or Future HIV Remission Options.
    Dubé K; Campbell DM; Perry KE; Kanazawa JT; Saberi P; Sauceda JA; Poteat T; Evans D
    AIDS Res Hum Retroviruses; 2020 Dec; 36(12):1054-1058. PubMed ID: 32829645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Qualitative Thematic Analysis of Social Media Data to Assess Perceptions of Route of Administration for Antiretroviral Treatment among People Living with HIV.
    Matza LS; Paulus TM; Garris CP; Van de Velde N; Chounta V; Deger KA
    Patient; 2020 Aug; 13(4):409-422. PubMed ID: 32356146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. If We Build It, Will They Come? Perceptions of HIV Cure-Related Research by People Living with HIV in Four U.S. Cities: A Qualitative Focus Group Study.
    Sylla L; Evans D; Taylor J; Gilbertson A; Palm D; Auerbach JD; Dubé K
    AIDS Res Hum Retroviruses; 2018 Jan; 34(1):56-66. PubMed ID: 29198134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Mixed Methods Approach to Understanding Antiretroviral Treatment Preferences: What Do Patients Really Want?
    Yelverton V; Ostermann J; Hobbie A; Madut D; Thielman N
    AIDS Patient Care STDS; 2018 Sep; 32(9):340-348. PubMed ID: 30179532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BREATHER (PENTA 16) short-cycle therapy (SCT) (5 days on/2 days off) in young people with chronic human immunodeficiency virus infection: an open, randomised, parallel-group Phase II/III trial.
    Butler K; Inshaw J; Ford D; Bernays S; Scott K; Kenny J; Klein N; Turkova A; Harper L; Nastouli E; Paparini S; Choudhury R; Rhodes T; Babiker A; Gibb D
    Health Technol Assess; 2016 Jun; 20(49):1-108. PubMed ID: 27377073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "Cure" Versus "Clinical Remission": The Impact of a Medication Description on the Willingness of People Living with HIV to Take a Medication.
    Fridman I; Ubel PA; Blumenthal-Barby J; England CV; Currier JS; Eyal N; Freedberg KA; Halpern SD; Kelley CF; Kuritzkes DR; Le CN; Lennox JL; Pollak KI; Zikmund-Fisher BJ; Scherr KA
    AIDS Behav; 2020 Jul; 24(7):2054-2061. PubMed ID: 31900813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 'Well, It's the Risk of the Unknown… Right?': A Qualitative Study of Perceived Risks and Benefits of HIV Cure Research in the United States.
    Dubé K; Taylor J; Sylla L; Evans D; Dee L; Burton A; Willenberg L; Rennie S; Skinner A; Tucker JD; Weiner BJ; Greene SB
    PLoS One; 2017; 12(1):e0170112. PubMed ID: 28122027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Participant Perspectives in an HIV Cure-Related Trial Conducted Exclusively in Women in the United States: Results from AIDS Clinical Trials Group 5366.
    Dubé K; Hosey L; Starr K; Barr L; Evans D; Hoffman E; Campbell DM; Simoni J; Sugarman J; Sauceda J; Brown B; Diepstra KL; Godfrey C; Kuritzkes DR; Wohl DA; Gandhi R; Scully E
    AIDS Res Hum Retroviruses; 2020 Apr; 36(4):268-282. PubMed ID: 32160755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preferences of people living with HIV for injectable and oral antiretroviral treatment in the Netherlands: a discrete choice experiment.
    Kremer IEH; Beaudart C; Simons J; Plieger H; Schroeder M; Hiligsmann M
    AIDS Care; 2024 Apr; 36(4):536-545. PubMed ID: 37526109
    [No Abstract]   [Full Text] [Related]  

  • 12. Assessment of satisfaction with antiretroviral drugs and the need for long-acting injectable medicines among people living with HIV in Japan and its associated factors: a prospective multicenter cross-sectional observational study.
    Ishihara M; Hikasa S; Tsukiji M; Kunimoto Y; Nobori K; Kimura T; Onishi K; Yamamoto Y; Haruta K; Kashiwabara Y; Fujii K; Shimabukuro S; Watanabe D; Tsurumi H; Suzuki A
    AIDS Res Ther; 2023 Aug; 20(1):62. PubMed ID: 37641099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ready for HIV Dual Therapy? - New Data from International HIV/AIDS Society 2017.
    Yendewa GA; Salata RA
    AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perceptions of HIV cure research among people living with HIV in Australia.
    Power J; Westle A; Dowsett GW; Lucke J; Tucker JD; Sugarman J; Lewin SR; Hill S; Brown G; Wallace J; Richmond J
    PLoS One; 2018; 13(8):e0202647. PubMed ID: 30142171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perceptions of Risks and Benefits of Participating in HIV Cure-Related Research Among Diverse Young Adults Living with HIV in the United States: Qualitative Research Findings.
    Saberi P; Campbell CK; Sauceda JA; Ndukwe S; Dubé K
    AIDS Res Hum Retroviruses; 2022 Aug; 38(8):649-659. PubMed ID: 35579937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acceptability and preferences for long-acting antiretroviral formulations among people with HIV infection.
    Dandachi D; Dang BN; Lucari B; Swindells S; Giordano TP
    AIDS Care; 2021 Jun; 33(6):801-809. PubMed ID: 32408771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiretroviral therapy experience, satisfaction, and preferences among a diverse sample of young adults living with HIV.
    Campbell CK; Dubé K; Sauceda JA; Ndukwe S; Saberi P
    AIDS Care; 2022 Sep; 34(9):1212-1218. PubMed ID: 34793253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "A dream come true": Perspectives on long-acting injectable antiretroviral therapy among female sex workers living with HIV from the Dominican Republic and Tanzania.
    Kerrigan D; Sanchez Karver T; Muraleetharan O; Savage V; Mbwambo J; Donastorg Y; Likindikoki S; Perez M; Gomez H; Mantsios A; Murray M; Beckham SW; Davis W; Galai N; Barrington C
    PLoS One; 2020; 15(6):e0234666. PubMed ID: 32530939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-Acting Injectable Antiretroviral Treatment Acceptability and Preferences: A Qualitative Study Among US Providers, Adults Living with HIV, and Parents of Youth Living with HIV.
    Simoni JM; Beima-Sofie K; Mohamed ZH; Christodoulou J; Tapia K; Graham SM; Ho R; Collier AC
    AIDS Patient Care STDS; 2019 Mar; 33(3):104-111. PubMed ID: 30844308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time to Engage Young People in HIV Cure Research.
    Saberi P; Campbell CK; Venegas M; Dubé K
    AIDS Res Hum Retroviruses; 2022 Jan; 38(1):2-4. PubMed ID: 33677996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.